TRIM29 and neoplasm: By univariate analysis using the log-rank test, there was a statistically significant difference in the 5-year survival between TRIM29-positive and TRIM29-negative tumors (TRIM29-positive tumor: median overall survival of 16.4 months, TRIM29-negative tumor: median overall survival of 32.3 months, P < 0.001, Figure 2(a)).